An allosteric SHP2 inhibitor suppresses breast cancer-induced osteoclastogenesis and bone lysis

Biochemical Pharmacology 2026

View at publisher

Authors: Qinghe Liang, Wenqi Dai, Jiehuang Zheng, Yan Chen, Lishan Chen, Ziye Chen, Zhihui Huang, jianchao chen, Jianxin Pang, Xiaojuan Li

DOI: 10.1016/j.bcp.2026.117810

Cited by: 0

References: 54

Fields of Study & Subjects

Bone Metabolism and Diseases Protein Tyrosine Phosphatases Bone health and treatments

References 54